Stock PPD PPD, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

PPD, Inc. Stock

Equities

PPD

US69355F1021

Biotechnology & Medical Research

Chart PPD, Inc.

Dynamic Chart

Latest news about PPD, Inc.

PPD, Inc. acquired Vigi Medsafe Private Limited from the shareholders of Vigi Medsafe . CI
Chilean court rejects appeal to stop tender for new lithium contracts RE
PPD, Inc.(NasdaqGS:PPD) dropped from S&P TMI Index CI
PPD, Inc.(NasdaqGS:PPD) dropped from S&P Global BMI Index CI
PPD, Inc.(NasdaqGS:PPD) dropped from NASDAQ Composite Index CI
Thermo Fisher Scientific Inc. completed the acquisition of PPD, Inc. from Hellman & Friedman Capital Partners VII, L.P. managed by Hellman & Friedman LLC, Carlyle Partners VI, L.P. managed by The Carlyle Group Inc. (NasdaqGS:CG) and others. CI
UK Regulator Clears Thermo Fisher's Acquisition of PPD MT
British Competition Watchdog Clears Thermo Fisher's $21 Billion PPD Purchase MT
FTSE 100 to Open Higher DJ
UK Regulator Won't Refer Thermo Fisher's Acquisition of PPD for Further Review DJ
EU to Decide on Thermo Fisher's $21 Billion PPD Purchase by Dec. 7 MT
EU antitrust decision on Thermo Fisher's PPD deal due by Dec. 7 RE
Transcript : PPD, Inc., Q3 2021 Earnings Call, Oct 28, 2021
Earnings Flash (PPD) PPD Posts Q3 Revenue $1.56B MT
Earnings Flash (PPD) PPD Reports Q3 EPS $0.43 MT
More news

Analyst Recommendations on PPD, Inc.

ANALYST RECOMMENDATIONS : Amgen, Biogen, Halfords, J Sainsbury, Uber... Our Logo
CORRECTION : Mizuho Securities Maintains Price Target for PPD at $47.50, Reiterates Neutral Rating MT
PPD : Mizuho Securities Adjusts PPD Price Target to $38 From $47.50, Maintains Neutral Rating MT
PPD : JPMorgan Downgrades PPD to Neutral from Overweight, Lifts PT to $48 From $42 MT
PPD : Jefferies Downgrades PPD to Hold Rating From Buy, Lifts PT to $47.50 From $43 MT
More recommendations

Press releases PPD, Inc.

PPD : Thermo Fisher Scientific Completes Acquisition of PPD, Inc - Form 8-K PU
PPD, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K) AQ
PPD Named to ‘Best Workplaces in Greater China’ for Second Consecutive Year BU
PPD Named ‘Best Vaccine CRO of the Year’ in Asia-Pacific BU
PPD Wins Multiple Awards at Clinical Researcher of the Year Competition BU
More press releases

News in other languages on PPD, Inc.

PUMP / DUMP #7
La croissance chinoise s'invite chez les sorcières
EN DIRECT DES MARCHES : L'Oréal, FDJ, Fnac Darty, HelloFresh, Daimler, GSK, Scor, Thermo Fisher, Alcoa...
PPD : Thermo Fisher übernimmt Auftragsforscher PPD für 21 Mrd Dollar
Dpa-AFX-Überblick: UNTERNEHMEN vom 15.04.2021 - 15.15 Uhr
More news

Managers and Directors - PPD, Inc.

Managers TitleAgeSince
Rob Petrie CTO
 Chief Tech/Sci/R&D Officer - 97-12-31
Karen Kaucic CTO
 Chief Tech/Sci/R&D Officer 64 08-12-31
Brainard Hartman ADM
 Chief Administrative Officer 60 01-06-30
Members of the board TitleAgeSince
Michael Boxer BRD
 Director/Board Member 62 21-12-07
Anthony Smith BRD
 Director/Board Member 62 21-12-07
Rob Petrie CTO
 Chief Tech/Sci/R&D Officer - 97-12-31
More insiders

Company Profile

PPD Inc is a United States-based company. The Company is engaged in providing clinical development and laboratory services to pharmaceutical, and biotechnology industries. It provides solutions such as early development, product development and consulting, site and patient centric solutions. It also provides laboratories such as bioanalytical lab, biomarker lab, central lab, and vaccine science lab.
Sector
Biotechnology & Medical Research
More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.12% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+6.77% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+47.70% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-11.96% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.01% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.92% 18.17B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.63% 11.7B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.16% 12.05B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.30% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PPD Stock